Details for New Drug Application (NDA): 088907
✉ Email this page to a colleague
NDA 088907 describes RESERPINE AND HYDROFLUMETHIAZIDE, which is a drug marketed by Ivax Pharms and Par Pharm and is included in two NDAs. Additional details are available on the RESERPINE AND HYDROFLUMETHIAZIDE profile page.
The generic ingredient in RESERPINE AND HYDROFLUMETHIAZIDE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
The generic ingredient in RESERPINE AND HYDROFLUMETHIAZIDE is hydroflumethiazide; reserpine. There are two drug master file entries for this compound. Additional details are available on the hydroflumethiazide; reserpine profile page.
Summary for 088907
| Tradename: | RESERPINE AND HYDROFLUMETHIAZIDE |
| Applicant: | Par Pharm |
| Ingredient: | hydroflumethiazide; reserpine |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG;0.125MG | ||||
| Approval Date: | Sep 20, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
